海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- The effect of Granolocyte Colony Stimulating Factor in treatment of Amyotrophic Lateral Sclerosis
- amyotrophic lateral sclerosis. Diseases of the nervous system;Diseases of the nervous system
- Iran (Islamic Republic of)
- 2012-08-17
Not recruiting
- First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients
- Non-Small Cell Lung Cancer
- China
- 2012-07-17
Not Recruiting
- Associations of CYP3A and ABCB1 Polymorphisms with Pharmacokinetics of Cyclosporine A in Early Renal Recipients after Transplantation
- Renal Transplantation
- China
- 2012-05-17
Not Recruiting
- An Open-label, Multicenter Phase II Study to Compare the Efficacy and Safety of RAD001 as First-line Followed by Second-line Sunitinib Versus Sunitinib as First-line Followed by Second-line RAD001 in the Treatment of Patients With Metastatic Renal Cell Carcinoma.
- Renal Cell Carcinoma;C65 - Malignant neoplasm of renal pelvis;C64 - Malignant neoplasm of kidney, except renal pelvis
- Argentina, Australia, Brazil, Canada, Denmark, France, Germany, Hong Kong, Italy, Korea, Republic of, Mexico, Netherlands, Peru, Spain, Taiwan, Province of China, Thailand, Turkey, United Kingdom, United States
- 2012-04-30
Not recruiting
- An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy
- Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction;Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction;Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction;Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal Junction
- France, Germany, Hong Kong, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Spain, Taiwan, United States
- 2012-04-25
Not recruiting
- Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma
- Pancreatic Adenocarcinoma;Pancreatic Adenocarcinoma;Pancreatic Adenocarcinoma;Pancreatic Adenocarcinoma
- Hong Kong
- 2012-03-18
Not Recruiting
- Selectively Regulating and Controlling Effect of Jiedu-quyu-ziyin therapeutic methods on Estrogen Receptor Subtypes in Lymphocytes of Systemic Lupus Erythematosus
- systemic lupus erythematosus
- China
- 2012-03-13
Recruiting
- Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma
- Gastric Adenocarcinoma
- China
- 2012-03-06
Recruiting
- Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma
- Colorectal Adenocarcinoma
- China
- 2012-03-05
Not recruiting
- Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma
- Liver Cancer;Liver Cancer;Liver Cancer;Liver Cancer
- Taiwan
- 2012-03-01
Not recruiting
- A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma
- Leukemia;Lymphoma;Leukemia;Lymphoma;Leukemia;Lymphoma;Leukemia;Lymphoma
- China
- 2012-02-29
Recruiting
- RAD001 in Advanced Gastric Cancer Who Failed Standard First-line Treatment With pS6 Ser 240/4 Expression
- ;Neoplasms
- Korea, Republic of
- 2012-02-09
Not Recruiting
- Randomised, Multicenter Phase III Clinical Study of Lipoplatin plus Gemcitabine Versus Gemcitabine as First-Line Treatment in Inoperable, Locally Advanced or Metastatic Pancreatic Cancer
- Patients with Inoperable, Locally Advanced or Metastatic Pancreatic Cancer, not previously treated with chemotherapy for the current disease;Therapeutic area: Diseases [C] - Cancer [C04]
- China, France, Germany, Greece, Israel, Italy, Poland, Romania, Russian Federation, Spain, Taiwan, Turkey, United Kingdom, United States
- 2012-02-01
Recruiting
- Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers
- Gastric Cancer
- China
- 2012-01-19
Not recruiting
- Efficacy and Safety of Simtuzumab With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
- Colorectal Cancer
- France, Germany, Italy, Poland, Russian Federation, Spain, United States
- 2011-11-09
Not recruiting
- A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients
- Colorectal Cancer
- Korea, Republic of
- 2013-12-31
Recruiting
- Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
- Pancreatic Cancer
- China
- 2013-12-26
Recruiting
- FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma
- Advanced Esophageal Carcinoma
- China
- 2013-12-16
Not Recruiting
- A Multinational, Randomized, Phase III Study of XELIRI with/without Bevacizumab versus FOLFIRI with/without Bevacizumab as Second-line Therapy in Patients with Metastatic Colorectal Cancer.
- Patients with 2nd-line treatment of mCRC
- Asia(except Japan), Japan
- 2013-11-11
Not Recruiting
- A single arm trial of cetuximab, FOLFIRI combined with NK as the second line region in metastatic K-ras positive colorectal cancer: the XQZL001 study
- colorectal cancer
- China
- 2013-11-08